Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis

Clinical trial NCT01195246 · COMPLETED

Trial details

NCT number: NCT01195246
Sponsor: Dynavax Technologies Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2010-12-01
Primary completion: 2012-02-01
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.